DETERMINATION OF COCAINE AND BENZOYLECGONINE IN HUMAN PLASMA BY LC-MS/MS
DETERMINATION OF COCAINE AND BENZOYLECGONINE IN HUMAN PLASMA BY LC-MS/MS
复制标题
采用 LC-MS/MS 测定人血浆中的可卡因和苯甲酰爱康宁
DOI:
--
复制
发表时间:
2009
期刊:
影响因子:
--
通讯作者:
F. Loghin
中科院分区:
文献类型:
--
作者:
D. Popa;L. Vlase;F. Loghin
A high-throughput Liquid chromatography/ Mass spectrometry/ Mass spectrometry (LC/MS/MS) method for simultaneous quantification of cocaine (COC) and benzoylecgonine (BZE) in human plasma was elaborated. After the protein precipitation with methanol in the plasma samples, the analytes were separated on a Zorbax SB-C18 column under isocratic conditions using a 32:68 (v/v) mixture of methanol and 0.1% formic acid in water at 45oC, with a flow rate of 1 mL/min. The detection was in multiple reaction monitoring (MRM) mode (m/z 290 → m/z 168 for BZE and m/z 304 → m/z 182 for COC, respectively). Calibration curves were generated over the range of 20-2000 ng/mL for both BZE and COC (r > 0.992). In the laboratories that are not equipped with a LC/MS/MS system, the LC analysis of COC and BZE requires a previous isolation step. Therefore, the elaborated LC/MS/MS method was applied for the study of optimum experimental conditions for the isolation of COC and BZE from human plasma. Several solvent mixtures and solid-phase extraction (SPE) cartridges were tested at different pH values. The best results for both analytes were obtained by SPE on Oasis HLB cartridges (mean recovery of 71 % for COC and 92.4 % for BZE, n = 3). Both the elaborated LC/MS/MS method and the best extraction conditions can successfully be applied in clinical and forensic toxicology for the rapid quantification of COC and BZE in human plasma. Rezumat S-a elaborat o metodă rapidă LC/MS/MS pentru cuantificarea simultană a cocainei (COC) si benzoilecgoninei (BZE) din plasma umană. După precipitarea proteinelor cu metanol in probele de plasmă, analiţii s-au separat pe o coloană Zorbax SBC18 in condiţii izocratice folosind un amestec 32:68 (v/v) de metanol si soluţie apoasă de acid formic 0,1%, la 45oC cu un debit de 1 mL/min. Detecţia s-a realizat in modul MRM (monitorizarea reacţiilor multiple) (m/z 290 → m/z 168 pentru BZE, respectiv m/z 304 → m/z 182 pentru COC). Curbele de calibrare s-au realizat pe domeniul de concentraţii 202000 ng/mL atât pentru BZE cât si pentru COC (r > 0.992). In laboratoarele care nu sunt echipate cu un sistem LC/MS/MS, analiza LC a COC si BZE necesită anterior o etapă de izolare. Astfel, metoda LC/MS/MS elaborată s-a aplicat in studiul condiţiilor experimentale optime necesare izolării COC si BZE din plasma umană. S-au testat mai multe amestecuri de solvenţi si cartuse de extracţie pe fază solidă (EFS) la diferite valori de pH. Cele mai bune rezultate s-au obţinut prin EFS cu cartuse Oasis HLB (regăsiri medii de 71 % pentru COC si 92.4 % pentru BZE). Atât metoda LC/MS/MS elaborată cât si cele mai bune metode de extracţie evidenţiate se pot aplica cu succes in toxicologia clinică si medicolegală in vederea dozării rapide a COC si BZE din plasma umană.